Cochlear Limited
CHEOY · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 4.8% | 14.3% | 19.2% | – |
| Cost of Goods Sold | $1 | $1 | $0 | $0 |
| Gross Profit | $2 | $2 | $1 | $1 |
| % Margin | 73.7% | 74.9% | 75% | 75% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $1 | $1 |
| Sales & Mktg Exp. | $1 | $1 | $1 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | $0 | $0 | $0 | $0 |
| % Margin | 17.3% | 21.2% | 21.1% | 22% |
| Other Income/Exp. Net | $0 | $0 | -$0 | -$0 |
| Pre-Tax Income | $1 | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 16.6% | 16% | 15.4% | 17.6% |
| EPS | 2.97 | 2.72 | 2.29 | 2.2 |
| % Growth | 9.2% | 18.8% | 4.1% | – |
| EPS Diluted | 2.97 | 2.72 | 2.28 | 2.2 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $0 | $0 |
| % Margin | 26.5% | 25.9% | 24.9% | 26.5% |